Michael J. Stender, M.D.
Mike Stender has been a willing and active participant in the MSHO Board of Directors since being elected in 2009, and has been treasurer for the past 5 years.
He is a quadruple degree holder from Wayne State University in Detroit. His undergraduate majors were Chemistry and Biology. Five years later, Mike received his Master of Science in Biological Sciences and after four more years of study, he graduated from the School of Medicine. Dr. Stender completed an internal medicine residency and a Medical Oncology and Hematology fellowship at Indiana University in Indianapolis. He is certified by the American Board of Internal Medicine with a subspecialty certificate in both medical oncology and hematology, and in 2010, became board certified in hospice and palliative care.
Dr. Stender’s research experience includes several years of molecular biology research at the Michigan Cancer Foundation. He was awarded the Fellowship Award by the American Society of Clinical Oncology in 1997 for outstanding research contribution in breast cancer. He continues to participate in clinical research as a local principle investigator in William Beaumont’s clinical trials program.
Dr. Stender is a partner at Cancer Care Associates in Royal Oak and is on staff at William Beaumont Hospital at both Royal Oak and Troy. At Royal Oak Beaumont, he is the A-South oncology unit director, one of the core clinical faculty members in the hematology/oncology fellowship program, and has been an assistant clinical professor at Oakland University School of Medicine since 2011.
In addition to MSHO, Dr. Stender is a member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians, American Medical Association, the Michigan State Medical Society, and has been elected a Fellow of the American College of Physicians.
When time allows, Mike enjoys traveling; his favorites include California Wine Country, New York, Paris, and especially his condo in Ft. Myers, FL.